ENIMMUNE CORPORATIENIMMUNE CORPORATIENIMMUNE CORPORATI

ENIMMUNE CORPORATI

No trades
See on Supercharts

6564 fundamentals

ENIMMUNE CORPORATI financial statements, including revenue, expenses, profit, and loss

The total revenue of 6564 for the last quarter is 16.60 M TWD, and it's 345.96% higher compared to the previous quarter. The net income of Q2 24 is -39.64 M TWD.

Q1 '24
Q2 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income